Longevity May be Impacted by Orthostatic Hypotension in LBD

The autonomic nervous system regulates functions in the body that are involuntary, such as blood pressure and digestion. This system malfunctions in LBD, causing problems with blood pressure regulation, urinary […]
Read More

Loss of Attention May Suggest Faster Progression to Dementia in Very Early LBD

Like other dementias, a person doesn’t develop Lewy body dementia (LBD) overnight. Very mild symptoms worsen over time until medical attention is needed. Sometimes several years pass before these earliest […]
Read More

Loss of Smell in Parkinson’s Disease Increases Risk of Dementia

The loss of smell is a common symptom in LBD, Parkinson’s disease and even Alzheimer’s disease. New research suggests the loss of smell in Parkinson’s disease (PD) may help predict […]
Read More

MCI with Visual Spatial or Attention Deficits Progresses to DLB over Alzheimer’s

A study by Tanis Ferman, PhD and colleagues at Mayo Clinic assessed the progression from mild cognitive impairment (MCI) to different forms of dementia. 337 people with mild cognitive impairment […]
Read More

National Institutes of Health Award $14 million for LBD Research

People who have LBD plus changes in the brain associated with Alzheimer’s disease tend to have more aggressive disease progression. However, science has not yet explained why these two disease […]
Read More

New Diagnostic Criteria Published for DLB

If you talk with families, many will share that getting a diagnosis for one specific form of LBD, called dementia with Lewy bodies (DLB), was a challenge.  Sometimes the diagnosis […]
Read More

New Research Definition of Mild Cognitive Impairment with Lewy bodies (MCI-LB)

Most people with Lewy body dementia (LBD) will experience mild changes in thinking; over time, these symptoms, referred to as mild cognitive impairment (MCI), worsen and may become dementia. As […]
Read More

NINDS: Hunting for an LBD Biomarker

Did you know that the National Institute of Neurological Disorders and Stroke (NINDS) plays a leading role in funding research on Lewy body disorders?  Because LBD and Parkinson’s disease share […]
Read More

Positive Results for the HARMONY Clinical Trial of Pimavanserin in Dementia-Related Psychosis

In December ACADIA Pharmaceuticals presented its top-line results from its Phase 3 clinical trial of pimavanserin in people who had dementia-related psychosis. The results had been eagerly awaited; ACADIA stopped […]
Read More

Preparing LBD Families about End of Life

End of life factors are known to be different in LBD compared to Alzheimer’s disease. The progression of LBD averages 5-7 years from onset to end of life. This is […]
Read More